Latest News
US close: Stocks end mixed despite inflation slowdown, Daly comments
US stocks finished mixed on Thursday, with the Dow edging higher but the S&P 500 and Nasdaq sinking sharply back from record highs, despite rising hopes that the Federal Reserve may cut interest rates sooner than anticipated.
Sector movers: Homebuilders, water utilities pace gains
Homebuilders and Utilities paced gains on Thursday following the release of a weaker-than-expected reading for US inflation in the month of June that weighed on longer-term government bond yields on either side of the Atlantic.
Europe close: Stoxx 600 hits one-month high as data lifts the mood
European stocks closed at their highest levels in a month on Thursday as improving economic data lifted sentiment across the continent.
London close: Stocks rise as US inflation slows more than expected
London stocks ended Thursday on a high note, buoyed by favourable economic data from both sides of the Atlantic.
Broker tips: Idox, Anglo American
Analysts at Berenberg initiated coverage on software specialist Idox with a 'buy' rating and 81. 0p target price on Thursday, citing an attractive geo-spatial opportunity.
Friday preview: US producer prices, Ashmore Group in focus
Inflation will continue to be in focus on either side of the Pond at the end of the week.
Supermarkets say card payment issues resolved
Card payment disruptions at major UK retailers were reportedly resolved by Thursday afternoon, after customers at chains including Asda, Sainsbury's, and various petrol stations reporting issues with both Visa and Mastercard transactions.
Director dealings: National Grid non-exec buys shares after capital raise
Earl Shipp, an independent non-executive director at National Grid, picked up some shares in the utilities group at the start of the third quarter.
Bain Capital to buy Envestnet in $4.5bn deal
Envestnet said on Thursday that it has agreed to be bought by Bain Capital in a $4. 5bn deal.
FTSE 100 movers: Water firms gush higher; DCC in the red
London’s FTSE 100 was up 0. 3% at 8,219. 41 in afternoon trade on Thursday.
US open: Markets rangebound but rate-cut hopes rise after CPI data
US stocks opened broadly flat on Thursday, with futures erasing earlier losses, as investors digested better-than-expected inflation and labour-market data and pondered over how the Federal Reserve may respond.
Ideagen abandons pursuit of Crimson Tide, shares slide
Crimson Tide tumbled on Thursday as it said that Ideagen had decided not to make an offer for the group.
US jobless claims fall more than forecast to five-week low
US jobless claims fell more than forecast last week, with the four-week moving average pulling back for the first time in five weeks.
US inflation drops to 12-month low in June
US inflation dropped to its lowest level in a year in June, tying the smallest rate of price growth since early 2021, according to figures released on Thursday from the Department of Labor Statistics.
UK water consumers slapped with 21% price hike by Ofwat
Britain’s long-suffering water customers will see bills rise by 21% over the next five years amid a continuing sewage pollution crisis, water regulator Ofwat said on Thursday, adding that it had put Thames Water into special measures over its poor performance.
UK's Miliband reportedly orders ban on new oil licences
New UK Energy Secretary Ed Miliband has reportedly ordered an immediate ban on issuing new licences to drill for oil in the North Sea.
RBC Capital downgrades Anglo American, cuts forecasts on Grosvenor fire
RBC Capital Markets downgraded Anglo American on Thursday to ‘sector perform’ from ‘outperform’ and cut the price target to 2,600p from 3,100p.
PepsiCo profits top expectations, revenue misses slightly
PepsiCo has reported a significant increase in its second-quarter profits on Thursday, surpassing Wall Street expectations despite a continuous decline in consumer demand for its snacks and beverages.
Faron gets positive FDA feedback on bexmarilimab study plans
Faron Pharmaceuticals announced positive feedback from the FDA regarding the clinical development plan for its drug candidate bexmarilimab, aimed at treating myelodysplastic syndrome (MDS), on Thursday.